Superfluid responds to community feedback by extending their 100% contribution bonus beyond the initial 24-hour window.
The bonus now applies to the entire @KaitoAI campaign, including the First-Come-First-Served (FCFS) phase.
- Campaign enters final FCFS phase
- Remaining SUP token allocation now open to public
- 100% bonus still active for all contributions
This extension demonstrates Superfluid's commitment to community input and provides more opportunities for participants to benefit from the doubled rewards.
You asked, we listened ๐ The 100% bonus isnโt stopping after 24h. Weโre extending it through the entire @KaitoAI campaign โ yes, including FCFS.
Weโre turning the taps on full blast! For the next 24 hours only: ๐ ๐๐๐% ๐๐จ๐ง๐ฎ๐ฌ ๐จ๐ง ๐๐ฅ๐ฅ ๐๐๐ ๐๐ฅ๐ฅ๐จ๐๐๐ญ๐ข๐จ๐ง๐ฌ via @KaitoAI Capital Launchpad Thatโs right, invest $100 โ get $200 worth of SUP First come, first served. Streams move fast. Yaps move faster. pic.x.com/sqmR0k5lud
SPR Season 2 Community Input Call & Season 1 Success
Superfluid Protocol Revenue (SPR) is preparing for Season 2 launch with an open call for community input. The protocol seeks innovative ideas for SUP token streaming mechanisms. Season 1 showed strong performance: - 1,300+ active SUP donation streams - ~1.4 ETH monthly volume - Successful Octant SQF round with FlowState Community members can now contribute ideas to shape the upcoming season's token distribution and mechanics.
Pipegate Launches API Monetization Layer Using Superfluid Streams
Frontier Guild builder @0xdhruva has introduced Pipegate, a new solution for API monetization using Superfluid streams. The platform eliminates common pain points in API integration: - Removes need for traditional API keys - Streamlines payment processing - Integrates AI-agent for automated management - Uses on-chain payment streams This development addresses a key infrastructure gap in web3, moving beyond technical limitations to solve real implementation challenges. The solution enables APIs to handle payments automatically through streaming protocols.